首页 > 最新文献

Journal of Clinical Outcomes Management最新文献

英文 中文
Quality of Life and Population Health in Behavioral Health Care: A Retrospective, Cross-Sectional Study 行为健康护理中的生活质量与人群健康:一项回顾性横断面研究
Q4 Medicine Pub Date : 2022-11-01 DOI: 10.12788/jcom.0114
W. M. Drymalski
Objectives: The goal of this study was to determine whether a single-item quality of life (QOL) measure could serve as a useful population health–level metric within the Quadruple Aim framework in a publicly funded behavioral health system. Design: This was a retrospective, cross-sectional study that examined the correlation between the single-item QOL measure and several other key measures of the social determinants of health and a composite measure of acute service utilization for all patients receiving mental health and substance use services in a community behavioral health system. Methods: Data were collected for 4488 patients who had at least 1 assessment between October 1, 2020, and September 30, 2021. Data on social determinants of health were obtained through patient self-report; acute service use data were obtained from electronic health records. Results: Statistical analyses revealed results in the expected direction for all relationships tested. Patients with higher QOL were more likely to report “Good” or better self-rated physical health, be employed, have a private residence, and report recent positive social interactions, and were less likely to have received acute services in the previous 90 days. Conclusion: A single-item QOL measure shows promise as a general, minimally burdensome whole-system metric that can function as a target for population health management efforts in a large behavioral health system. Future research should explore whether this QOL measure is sensitive to change over time and examine its temporal relationship with other key outcome metrics.
目的:本研究的目的是确定在公共资助的行为健康系统中,单项生活质量(QOL)指标是否可以作为四重目标框架内有用的人群健康水平指标。设计:这是一项回顾性的横断面研究,研究了单项生活质量指标与健康社会决定因素的其他几个关键指标之间的相关性,以及在社区行为健康系统中接受心理健康和药物使用服务的所有患者急性服务利用率的综合指标。方法:收集了4488名患者的数据,这些患者在2020年10月1日至2021年9月30日期间至少进行了一次评估。关于健康的社会决定因素的数据是通过患者自我报告获得的;急性服务使用数据来自电子健康记录。结果:统计分析显示,所有测试关系的结果都符合预期方向。生活质量较高的患者更有可能报告“良好”或自我评价更好的身体健康状况,有工作,有私人住所,最近有积极的社交互动,并且在过去90天内接受急性服务的可能性较小。结论:单项生活质量指标有望成为一种通用的、负担最小的全系统指标,可以作为大型行为健康系统中人群健康管理工作的目标。未来的研究应该探索这种生活质量指标是否对随时间的变化敏感,并检查其与其他关键结果指标的时间关系。
{"title":"Quality of Life and Population Health in Behavioral Health Care: A Retrospective, Cross-Sectional Study","authors":"W. M. Drymalski","doi":"10.12788/jcom.0114","DOIUrl":"https://doi.org/10.12788/jcom.0114","url":null,"abstract":"Objectives: The goal of this study was to determine whether a single-item quality of life (QOL) measure could serve as a useful population health–level metric within the Quadruple Aim framework in a publicly funded behavioral health system. Design: This was a retrospective, cross-sectional study that examined the correlation between the single-item QOL measure and several other key measures of the social determinants of health and a composite measure of acute service utilization for all patients receiving mental health and substance use services in a community behavioral health system. Methods: Data were collected for 4488 patients who had at least 1 assessment between October 1, 2020, and September 30, 2021. Data on social determinants of health were obtained through patient self-report; acute service use data were obtained from electronic health records. Results: Statistical analyses revealed results in the expected direction for all relationships tested. Patients with higher QOL were more likely to report “Good” or better self-rated physical health, be employed, have a private residence, and report recent positive social interactions, and were less likely to have received acute services in the previous 90 days. Conclusion: A single-item QOL measure shows promise as a general, minimally burdensome whole-system metric that can function as a target for population health management efforts in a large behavioral health system. Future research should explore whether this QOL measure is sensitive to change over time and examine its temporal relationship with other key outcome metrics.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48122875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to System Quality Improvement in Health Care 卫生保健系统质量改进的障碍
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.12788/jcom.0110
E. Barkoudah
{"title":"Barriers to System Quality Improvement in Health Care","authors":"E. Barkoudah","doi":"10.12788/jcom.0110","DOIUrl":"https://doi.org/10.12788/jcom.0110","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48522449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abbreviated Delirium Screening Instruments: Plausible Tool to Improve Delirium Detection in Hospitalized Older Patients 简易谵妄筛查仪器:提高住院老年患者谵妄检测的可行工具
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.12788/jcom.0111
Doan
William W. Hung, MD, MPH Icahn School of Medicine at Mount Sinai New York, NY Outcomes Research in Review Section editorS daniel iSaac, do, mS Michigan State University East Lansing, MI Fred Ko, md, mS Icahn School of Medicine at Mount Sinai New York, NY taiSHi Hirai, md University of Missouri Columbia, MO Abbreviated Delirium Screening Instruments: Plausible Tool to Improve Delirium Detection in Hospitalized Older Patients
William W. Hung,医学博士,公共卫生硕士,纽约西奈山伊坎医学院结果研究综述部分编辑daniel iSaac, do,密歇根州立大学东兰辛分校,MI Fred Ko,医学博士,纽约西奈山伊坎医学院,NY taiSHi Hirai, MD密苏里大学哥伦比亚分校,MO缩短谵妄筛查仪器:改善住院老年患者谵妄检测的合理工具
{"title":"Abbreviated Delirium Screening Instruments: Plausible Tool to Improve Delirium Detection in Hospitalized Older Patients","authors":"Doan","doi":"10.12788/jcom.0111","DOIUrl":"https://doi.org/10.12788/jcom.0111","url":null,"abstract":"William W. Hung, MD, MPH Icahn School of Medicine at Mount Sinai New York, NY Outcomes Research in Review Section editorS daniel iSaac, do, mS Michigan State University East Lansing, MI Fred Ko, md, mS Icahn School of Medicine at Mount Sinai New York, NY taiSHi Hirai, md University of Missouri Columbia, MO Abbreviated Delirium Screening Instruments: Plausible Tool to Improve Delirium Detection in Hospitalized Older Patients","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66805457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Inpatient COVID-19 Vaccination Rates Among Adult Patients at a Tertiary Academic Medical Center 提高高等院校医疗中心成年患者新冠肺炎住院疫苗接种率
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.12788/jcom.0108
Guzmán
Objective: Inpatient vaccination initiatives are well described in the literature. During the COVID-19 pandemic, hospitals began administering COVID-19 vaccines to hospitalized patients. Although vaccination rates increased, there remained many unvaccinated patients despite community efforts. This quality improvement project aimed to increase the COVID-19 vaccination rates of hospitalized patients on the medicine service at the George Washington University Hospital (GWUH). Method(s): From November 2021 through February 2022, we conducted a Plan-Do-Study-Act (PDSA) cycle with 3 phases. Initial steps included gathering baseline data from the electronic health record and consulting stakeholders. The first 2 phases focused on educating housestaff on the availability, ordering process, and administration of the Pfizer vaccine. The third phase consisted of developing educational pamphlets for patients to be included in their admission packets. Result(s): The baseline mean COVID-19 vaccination rate (August to October 2021) of eligible patients on the medicine service was 10.7%. In the months after we implemented the PDSA cycle (November 2021 to February 2022), the mean vaccination rate increased to 15.4%. Conclusion(s): This quality improvement project implemented measures to increase administration of the Pfizer vaccine to eligible patients admitted to the medicine service at GWUH. The mean vaccination rate increased from 10.7% in the 3 months prior to implementation to 15.4% during the 4 months post implementation. Other measures to consider in the future include increasing the availability of other COVID-19 vaccines at our hospital and incorporating the vaccine into the admission order set to help facilitate vaccination early in the hospital course. Copyright © 2022 Turner White Communications Inc.. All rights reserved.
目的:住院患者的疫苗接种计划在文献中有很好的描述。在新冠肺炎大流行期间,医院开始为住院患者接种新冠肺炎疫苗。尽管疫苗接种率有所提高,但尽管社区做出了努力,仍有许多患者未接种疫苗。该质量改进项目旨在提高乔治华盛顿大学医院(GWUH)医疗服务住院患者的新冠肺炎疫苗接种率。方法:从2021年11月到2022年2月,我们进行了一个分为3个阶段的计划-实践-研究法案(PDSA)周期。最初的步骤包括从电子健康记录中收集基线数据,并咨询利益攸关方。前两个阶段的重点是教育家庭工作人员辉瑞疫苗的可用性、订购过程和管理。第三阶段包括为患者编写教育小册子,将其纳入入院包中。结果:符合条件的医疗服务患者的基线平均新冠肺炎疫苗接种率(2021年8月至10月)为10.7%。在我们实施PDSA周期后的几个月内(2021年11月至2022年2月),平均疫苗接种率提高到15.4%。结论:该质量改进项目实施了一些措施,以增加GWUH医疗服务中合格患者的辉瑞疫苗接种量。平均疫苗接种率从实施前3个月的10.7%增加到实施后4个月的15.4%。未来需要考虑的其他措施包括增加我院其他新冠肺炎疫苗的供应量,并将疫苗纳入入院令,以帮助在住院早期接种疫苗。版权所有©2022 Turner White Communications股份有限公司。保留所有权利。
{"title":"Improving Inpatient COVID-19 Vaccination Rates Among Adult Patients at a Tertiary Academic Medical Center","authors":"Guzmán","doi":"10.12788/jcom.0108","DOIUrl":"https://doi.org/10.12788/jcom.0108","url":null,"abstract":"Objective: Inpatient vaccination initiatives are well described in the literature. During the COVID-19 pandemic, hospitals began administering COVID-19 vaccines to hospitalized patients. Although vaccination rates increased, there remained many unvaccinated patients despite community efforts. This quality improvement project aimed to increase the COVID-19 vaccination rates of hospitalized patients on the medicine service at the George Washington University Hospital (GWUH). Method(s): From November 2021 through February 2022, we conducted a Plan-Do-Study-Act (PDSA) cycle with 3 phases. Initial steps included gathering baseline data from the electronic health record and consulting stakeholders. The first 2 phases focused on educating housestaff on the availability, ordering process, and administration of the Pfizer vaccine. The third phase consisted of developing educational pamphlets for patients to be included in their admission packets. Result(s): The baseline mean COVID-19 vaccination rate (August to October 2021) of eligible patients on the medicine service was 10.7%. In the months after we implemented the PDSA cycle (November 2021 to February 2022), the mean vaccination rate increased to 15.4%. Conclusion(s): This quality improvement project implemented measures to increase administration of the Pfizer vaccine to eligible patients admitted to the medicine service at GWUH. The mean vaccination rate increased from 10.7% in the 3 months prior to implementation to 15.4% during the 4 months post implementation. Other measures to consider in the future include increasing the availability of other COVID-19 vaccines at our hospital and incorporating the vaccine into the admission order set to help facilitate vaccination early in the hospital course. Copyright © 2022 Turner White Communications Inc.. All rights reserved.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48780697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diabetes Population Health Innovations in the Age of COVID-19: Insights From the T1D Exchange Quality Improvement Collaborative 新冠肺炎时代糖尿病人群健康创新:来自T1D交换质量改进协作的见解
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.12788/jcom.0109
Mungmode
There have been remarkable innovations in diabetes management since the start of the COVID-19 pandemic, but these groundbreaking innovations are drawing limited focus as the field focuses on the adverse impact of the pandemic on patients with diabetes. This article reviews select population health innovations in diabetes management that have become available over the past 2 years of the COVID-19 pandemic from the perspective of the T1D Exchange Quality Improvement Collaborative, a learning health network that focuses on improving care and outcomes for individuals with type 1 diabetes (T1D). Such innovations include expanded telemedicine access, collection of real-world data, machine learning and artificial intelligence, and new diabetes medications and devices. In addition, multiple innovative studies have been undertaken to explore contributors to health inequities in diabetes, and advocacy efforts for specific populations have been successful. Looking to the future, work is required to explore additional health equity successes that do not further exacerbate inequities and to look for additional innovative ways to engage people with T1D in their health care through conversations on social determinants of health and societal structures. Copyright © 2022 Turner White Communications Inc.. All rights reserved.
自2019冠状病毒病大流行开始以来,糖尿病管理方面取得了显著创新,但这些突破性创新受到的关注有限,因为该领域的重点是大流行对糖尿病患者的不利影响。本文从T1D交流质量改进协作的角度回顾了过去2年COVID-19大流行期间糖尿病管理方面的人口健康创新,T1D交流质量改进协作是一个专注于改善1型糖尿病(T1D)患者的护理和结果的学习健康网络。这些创新包括扩大远程医疗访问,收集真实世界的数据,机器学习和人工智能,以及新的糖尿病药物和设备。此外,还开展了多项创新研究,探讨糖尿病方面健康不平等的原因,针对特定人群的宣传工作也取得了成功。展望未来,需要努力探索在不进一步加剧不平等的情况下取得更多的卫生公平成功,并寻找更多的创新方法,通过关于健康的社会决定因素和社会结构的对话,使T1D患者参与其卫生保健。版权所有©2022特纳怀特通信公司。版权所有。
{"title":"Diabetes Population Health Innovations in the Age of COVID-19: Insights From the T1D Exchange Quality Improvement Collaborative","authors":"Mungmode","doi":"10.12788/jcom.0109","DOIUrl":"https://doi.org/10.12788/jcom.0109","url":null,"abstract":"There have been remarkable innovations in diabetes management since the start of the COVID-19 pandemic, but these groundbreaking innovations are drawing limited focus as the field focuses on the adverse impact of the pandemic on patients with diabetes. This article reviews select population health innovations in diabetes management that have become available over the past 2 years of the COVID-19 pandemic from the perspective of the T1D Exchange Quality Improvement Collaborative, a learning health network that focuses on improving care and outcomes for individuals with type 1 diabetes (T1D). Such innovations include expanded telemedicine access, collection of real-world data, machine learning and artificial intelligence, and new diabetes medications and devices. In addition, multiple innovative studies have been undertaken to explore contributors to health inequities in diabetes, and advocacy efforts for specific populations have been successful. Looking to the future, work is required to explore additional health equity successes that do not further exacerbate inequities and to look for additional innovative ways to engage people with T1D in their health care through conversations on social determinants of health and societal structures. Copyright © 2022 Turner White Communications Inc.. All rights reserved.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48783244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Deprescribing in Older Adults in Community and Nursing Home Settings 社区和疗养院环境中老年人的描述
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.12788/jcom.0112
Hung
{"title":"Deprescribing in Older Adults in Community and Nursing Home Settings","authors":"Hung","doi":"10.12788/jcom.0112","DOIUrl":"https://doi.org/10.12788/jcom.0112","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46069313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comorbidity Coding and Its Impact on Hospital Complexity 共病编码及其对医院复杂性的影响
Q4 Medicine Pub Date : 2022-07-01 DOI: 10.12788/jcom.0101
Kerguelen
{"title":"Comorbidity Coding and Its Impact on Hospital Complexity","authors":"Kerguelen","doi":"10.12788/jcom.0101","DOIUrl":"https://doi.org/10.12788/jcom.0101","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45006550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trastuzumab Deruxtecan in HER2-Positive Breast Cancer 曲妥珠单抗治疗HER2阳性乳腺癌症
Q4 Medicine Pub Date : 2022-07-01 DOI: 10.12788/jcom.0104
Isaac
{"title":"Trastuzumab Deruxtecan in HER2-Positive Breast Cancer","authors":"Isaac","doi":"10.12788/jcom.0104","DOIUrl":"https://doi.org/10.12788/jcom.0104","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41381411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Mission of Continuous Improvement in Health Care: A New Era for Clinical Outcomes Management 持续改进医疗保健的使命:临床结果管理的新时代
Q4 Medicine Pub Date : 2022-07-01 DOI: 10.12788/jcom.0106
Barkoudah
{"title":"The Mission of Continuous Improvement in Health Care: A New Era for Clinical Outcomes Management","authors":"Barkoudah","doi":"10.12788/jcom.0106","DOIUrl":"https://doi.org/10.12788/jcom.0106","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41574504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Epistaxis Knowledge and Management Among Nursing Staff 提高护理人员鼻出血知识和管理水平
Q4 Medicine Pub Date : 2022-07-01 DOI: 10.12788/jcom.0100
Nelson
{"title":"Improving Epistaxis Knowledge and Management Among Nursing Staff","authors":"Nelson","doi":"10.12788/jcom.0100","DOIUrl":"https://doi.org/10.12788/jcom.0100","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43050112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Outcomes Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1